Literature DB >> 27964797

The role of psychological factors in inflammatory rheumatic diseases: From burden to tailored treatment.

Henriët van Middendorp1, Andrea W M Evers2.   

Abstract

Inflammatory rheumatic diseases have a long-lasting effect on patients' physical and psychological functioning, for instance, due to disabling symptoms and unpredictable disease course. Consequently, many patients show adjustment problems such as depressed mood, which in turn can negatively influence their disease outcome. Specific biopsychosocial factors have shown to affect this outcome. For example, daily stress, cognitive-behavioral risk factors such as pain catastrophizing and avoidance, and resilience factors such as optimism and social support influence the quality of life, physical symptoms of pain and fatigue, and inflammatory markers. Psychological interventions tackling these factors can have beneficial effects on physical and psychological functioning. Recent advances in screening for patients at risk, tailored treatment, and eHealth further broaden the efficiency and scope of these interventions while simultaneously optimizing patient empowerment. This chapter describes the biopsychosocial risk and resilience factors related to disease outcome and the possible benefits of psychological treatment strategies in inflammatory rheumatic diseases.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adjustment problems; Cognitive-behavioral factors; Psychology; Rheumatic disease; Stress

Mesh:

Year:  2016        PMID: 27964797     DOI: 10.1016/j.berh.2016.10.012

Source DB:  PubMed          Journal:  Best Pract Res Clin Rheumatol        ISSN: 1521-6942            Impact factor:   4.098


  7 in total

1.  Investigation of Acceptance of Illness and Religious Coping in Patients with Familial Mediterranean Fever in Turkey.

Authors:  Sibel Şentürk; Alev Yıldırım Keskin; Şule Turan
Journal:  J Relig Health       Date:  2022-05-23

2.  Functional and psychosocial impact of COVID-19 pandemic on rheumatic patients' quality of life in Saudi Arabia.

Authors:  Lena M Hassen; Rana A Albarrak; Reem A Albahlal; Dimah K Alsaqabi; Ikhlass M Hassen; Maha H Daghestani; Eman M Alqurtas; Abdulaziz T Alkhalaf; Mohammed K Bedaiwi; Mohammed A Omair; Ibrahim A Almaghlouth
Journal:  Qual Life Res       Date:  2022-07-20       Impact factor: 3.440

3.  E-HEalth treatment in Long-term Dialysis (E-HELD): study protocol for a multicenter randomized controlled trial evaluating personalized Internet-based cognitive-behavioral therapy in dialysis patients.

Authors:  Judith Tommel; Andrea W M Evers; Henk W van Hamersvelt; Sandra van Dijk; Niels H Chavannes; Lieke Wirken; Luuk B Hilbrands; Henriët van Middendorp
Journal:  Trials       Date:  2022-06-07       Impact factor: 2.728

4.  What Are the Preferences of Patients With Rheumatoid Arthritis for Treatment Modification? A Scoping Review.

Authors:  Suz Jack Chan; Hui Yee Yeo; Lisa K Stamp; Gareth J Treharne; Carlo A Marra
Journal:  Patient       Date:  2020-12-18       Impact factor: 3.883

Review 5.  Chronic Pain in Inflammatory Arthritis: Mechanisms, Metrology, and Emerging Targets-A Focus on the JAK-STAT Pathway.

Authors:  Fausto Salaffi; Giovanni Giacobazzi; Marco Di Carlo
Journal:  Pain Res Manag       Date:  2018-02-07       Impact factor: 3.037

6.  Diagnosis and initial management in psoriatic arthritis: a qualitative study with patients.

Authors:  Emma Dures; Clive Bowen; Mel Brooke; Jane Lord; William Tillett; Neil McHugh; Sarah Hewlett
Journal:  Rheumatol Adv Pract       Date:  2019-08-26

7.  Expectancies as predictors of symptom improvement after antimicrobial therapy for persistent symptoms attributed to Lyme disease.

Authors:  Henriët van Middendorp; Anneleen Berende; Fidel J Vos; Hadewych H M Ter Hofstede; Bart Jan Kullberg; Andrea W M Evers
Journal:  Clin Rheumatol       Date:  2021-05-24       Impact factor: 2.980

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.